Skip to main content
Year archive

HYUNDAI PHARMACEUTICAL CO., LTD — 2022 filings

All 19 regulatory filings released by HYUNDAI PHARMACEUTICAL CO., LTD (004310) in 2022, sourced directly from the official regulator.

19 Filings
2022 Period
2022 filings (19)
Filing Released Lang
[기재정정]분기보고서 (2022.08)
Interim / Quarterly Report 9M 2022
2022-10-20 Korean
분기보고서 (2022.08)
Interim / Quarterly Report 9M 2022
2022-10-17 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares
2022-09-28 Korean
반기보고서 (2022.05)
Interim / Quarterly Report H1 2022
2022-07-15 Korean
공정거래자율준수프로그램운영현황(안내공시)
Governance Information
2022-07-14 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares
2022-06-23 Korean
투자판단관련주요경영사항
M&A Activity
2022-04-18 Korean
분기보고서 (2022.02)
Interim / Quarterly Report Q1 2022
2022-04-14 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-02-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2022-02-24 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-02-16 Korean
사업보고서 (2021.11)
Annual Report FY 2021
2022-02-16 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement
2022-02-10 Korean
[기재정정]주주총회소집결의
AGM Information
2022-02-09 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2022-02-09 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2022-02-08 Korean
공정거래자율준수프로그램운영현황(안내공시)
Governance Information
2022-02-08 Korean
주주총회소집결의
AGM Information
2022-02-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2021
2022-01-10 Korean